Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

AIDS dementia reversed by highly active antiretroviral therapy

Sep. 25, 1997

No Comments

Short-term efficacy and safety of T-20 in HIV infection

Sep. 25, 1997

No Comments

Oxandrolone + glutamine for HIV-associated wasting

Sep. 25, 1997

No Comments

Columbia Laboratories issued U.S. patent for drug delivery technology

Sep. 23, 1997

No Comments

Phase I results with HGP-30 AIDS vaccine reported

Sep. 22, 1997

No Comments

Efavirenz/indinavir combination shows efficacy in phase II

Sep. 18, 1997

No Comments

GEM-92 enters clinical trials for AIDS

Sep. 18, 1997

No Comments

AIDS rate increases among women

Sep. 17, 1997

No Comments

Clinical results reported for protease inhibitor/nucleoside analogue combination

Sep. 12, 1997

No Comments

Clinical evaluation planned for anti-HIV compound with novel mechanism of action

Sep. 8, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

HIV/AIDS
RSS

AIDS dementia reversed by highly active antiretroviral therapy

Short-term efficacy and safety of T-20 in HIV infection

Oxandrolone + glutamine for HIV-associated wasting

Columbia Laboratories issued U.S. patent for drug delivery technology

Phase I results with HGP-30 AIDS vaccine reported

Efavirenz/indinavir combination shows efficacy in phase II

GEM-92 enters clinical trials for AIDS

AIDS rate increases among women

Clinical results reported for protease inhibitor/nucleoside analogue combination

Clinical evaluation planned for anti-HIV compound with novel mechanism of action

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

HIV/AIDS RSS

HIV/AIDS
RSS